+51.2%
FHN vs BBIO
+78.3%
-27.0%
-60.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.1% | -2.8% | +0.7% | -1.9% |
| 7D | -7.5% | -2.9% | -4.6% | -7.4% |
| 30D | -6.2% | +12.2% | -18.4% | -6.8% |
| 3M | -11.2% | -8.3% | -2.9% | -10.9% |
| 6M | -9.0% | +11.4% | -20.4% | -9.6% |
| YTD | -7.0% | -0.6% | -6.4% | -7.4% |
| 1Y | +5.0% | +17.7% | -12.6% | +3.7% |
| 3Y | +95.1% | +160.0% | -65.0% | +83.9% |
| All | +51.2% | +78.3% | -27.0% | +34.3% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling